Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology

Pitfalls of using estimations of glomerular filtration rate in an intensive care population

(2011) J. H. Martin et al.   INTERNAL MEDICINE JOURNAL

Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients

(2011) Jason A Roberts et al.   BMC Anesthesiology

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey

(2010) Michael A. Barras et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Gentamicin pharmacokinetics in old age and frailty

(2010) Sarah N. Hilmer et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology

(2010) T. C. Pearson et al.   BRITISH JOURNAL OF HAEMATOLOGY

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

(2010) Michael J. Hanley et al.   CLINICAL PHARMACOKINETICS

Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice

(2010) James W. Behan et al.   PHARMACOLOGICAL RESEARCH

Estimation of creatinine clearance in morbidly obese patients

(2009) Jasmina A. Demirovic et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Effect of body mass index on the outcome of infections: a systematic review

(2009) M. E. Falagas et al.   Obesity Reviews

Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

(2008) Vincent Launay-Vacher et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide Survey

(2008) Kathryn M. Field et al.   Journal of Oncology Practice